Wellington Management Group LLP Takes $29.60 Million Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Wellington Management Group LLP acquired a new position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 461,333 shares of the company's stock, valued at approximately $29,599,000. Wellington Management Group LLP owned 0.18% of Ryan Specialty as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. JPMorgan Chase & Co. grew its stake in shares of Ryan Specialty by 107.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company's stock worth $30,504,000 after buying an additional 238,064 shares during the last quarter. Bar Harbor Wealth Management boosted its holdings in Ryan Specialty by 5.9% in the fourth quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company's stock worth $10,835,000 after acquiring an additional 9,482 shares in the last quarter. Barclays PLC grew its stake in shares of Ryan Specialty by 1.1% in the third quarter. Barclays PLC now owns 1,641,743 shares of the company's stock worth $108,994,000 after acquiring an additional 17,267 shares during the last quarter. Teachers Retirement System of The State of Kentucky increased its holdings in shares of Ryan Specialty by 51.5% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 30,760 shares of the company's stock valued at $2,042,000 after acquiring an additional 10,460 shares in the last quarter. Finally, HighTower Advisors LLC raised its position in shares of Ryan Specialty by 101.6% in the 3rd quarter. HighTower Advisors LLC now owns 39,969 shares of the company's stock worth $2,661,000 after purchasing an additional 20,139 shares during the last quarter. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Ryan Specialty Stock Performance

Shares of NYSE:RYAN traded up $0.81 during trading on Friday, hitting $72.76. The company's stock had a trading volume of 929,680 shares, compared to its average volume of 940,597. The company has a 50-day moving average of $70.05 and a 200-day moving average of $68.86. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a market cap of $19.06 billion, a price-to-earnings ratio of 105.45, a P/E/G ratio of 1.19 and a beta of 0.66. Ryan Specialty Holdings, Inc. has a 12 month low of $48.48 and a 12 month high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). The business had revenue of $663.53 million for the quarter, compared to analysts' expectations of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. On average, sell-side analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were given a $0.12 dividend. This is a boost from Ryan Specialty's previous quarterly dividend of $0.11. The ex-dividend date of this dividend was Tuesday, March 4th. This represents a $0.48 dividend on an annualized basis and a yield of 0.66%. Ryan Specialty's dividend payout ratio is presently 69.57%.

Insider Transactions at Ryan Specialty

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock in a transaction on Monday, January 13th. The shares were sold at an average price of $65.06, for a total transaction of $1,917,057.96. Following the transaction, the director now owns 45,409 shares in the company, valued at approximately $2,954,309.54. This trade represents a 39.35 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 241,360 shares of company stock valued at $16,006,428 over the last quarter. 11.10% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have issued reports on RYAN shares. Barclays decreased their target price on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a report on Friday. UBS Group upped their price objective on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Wells Fargo & Company reduced their target price on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a report on Thursday. TD Cowen assumed coverage on Ryan Specialty in a report on Thursday. They set a "buy" rating and a $89.00 price target on the stock. Finally, Keefe, Bruyette & Woods reduced their price objective on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $75.67.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.